• Oncoclínicas suspended its extraordinary shareholder meeting scheduled for Nov. 6, 2026, at 10 a.m. under a court order.
• Josephina III Fundo de Investimentos em Participações sought the injunction, which also suspended the Oct. 6, 2026, meeting notice.
• The suspension remains until a new meeting is called with prior board authorization or the competent arbitral tribunal rules otherwise.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oncoclinicas do Brasil Servicos Medicos SA published the original content used to generate this news brief on November 06, 2026, and is solely responsible for the information contained therein.